Cover Image


Protein Kinase Inhibitors in Oncology: Analytical Tool

出版商 BioSeeker Group AB 商品编码 166080
出版日期 内容信息 英文
商品交期: 最快1-2个工作天内
Back to Top
分析工具:癌症治疗的蛋白激脢抗化剂 Protein Kinase Inhibitors in Oncology: Analytical Tool
出版日期: 2016年08月22日 内容信息: 英文



  • <调查报告书> 癌症的癌蛋白激脢治疗(商品编码:103311)
    • 第1章 实施摘要
    • 第2章 关于癌症
    • 第3章 调查方法
    • 第4章 目录
    • 第5章 介绍
    • 第6章 最大的治疗效果来提升投资回收率的治疗标靶
      • 药剂重新定位
      • 蛋白激脢治疗标靶
      • 癌基因组计划和蛋白激脢治疗标靶
      • 蛋白激脢治疗的构造基础药剂设计
      • 所特定的蛋白激脢治疗标靶间的相互作用
      • 药剂和标靶的交互作用体
      • 路径分析
    • 第7章 新产品抬头
      • 结束的药剂标靶介绍
      • 登录前上市准备阶段
      • 第3期临床试验
      • 第2期临床试验
      • 第1期临床试验
      • 前临床试验
      • 癌治疗用蛋白激脢药剂的介绍
    • 第8章 化合物策略:各种化合物蛋白激脢治疗药的竞争标竿学习
      • 小分子
      • 缩氨酸・蛋白质药剂
      • 抗体、抗体样品构造
      • 核酸治疗
      • 细胞・基因治疗
      • 蛋白激脢治疗药的近似性竞争
      • 蛋白激脢治疗标靶的类细胞地方化为基础的化合物策略
    • 第9章 蛋白激脢治疗药对癌症的适应
      • 急性淋巴性白血病
      • 急性骨髓性白血病
      • 肾上腺癌
      • B细胞淋巴瘤
      • 良性摄护腺肥大症
      • 胆道癌 其他
    • 第10章 投资计画
    • 第11章 免责事项
    • 第12章 药剂索引
    • 第13章 企业索引
  • <数据库>癌治疗的蛋白激脢抗化剂生产线:(商品编码:171785)
    • 临床试验负责医师
    • 药剂名异名
      • 商标名
      • 非专利药
      • 编码名
    • 开发阶段
      • 开发中的520个药剂最新趋势
      • 已上市
      • 已登录
      • 登录前
      • 第3期
      • 第2期
      • 第1期
      • 前临床
      • 无数据
      • 中断
      • 中止
    • 适应
    • 标靶
      • 187的标靶分45类
    • 标靶发现介绍
    • 路径
    • 机制
    • 化合物
    • 药剂介绍
      • 药剂名
      • 临床试验负责医师及夥伴
      • 标靶及标靶的分子功能
      • 标靶的部位
      • 标靶发现介绍
      • 标靶讯号路径
      • 机制
      • 开发计画
      • 药剂解说
      • 化合物数据
      • 专利数据
      • 商业及市场
      • 第3期数据
      • 第2期数据
      • 第1期数据
      • 临床前数据
      • 专利数据
    • 应用特性
    • 系统必要条件
      • Operating system: Windows (2000/XP/Vista/7/8) for Mac Users the service is only available online
      • Browser Application (Internet Explorer, Firefox, Chrome, Safari)
      • Internet access (to access related internet resources)



Product Code: BSG060223

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals from a business development, drug development or investment perspective.

BioSeeker's Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering:

  • Target Scouting
  • Early & Late Stage Pipeline Analysis
  • Biomarker/Companion Diagnostic Analysis
  • Deal & Alliance Analysis
  • Combination Therapy Analysis
  • Indication Selection & Expansion Analysis
  • First-in-Class Analysis
  • Drug Repositioning
  • Pipeline Analysis by Targeted Pathways

Analytical Tools transform your computer's desktop into a high capacity workbench within your area of choice. Even before launching this desktop app you have already eliminated hundreds of hours of work needed to discover, process and piece together the thousands of sources that our team of oncology dedicated and highly experienced contents specialists have done on your behalf. It covers more than 463 companies plus partners who are today developing 1541 protein kinase inhibitors in oncology drugs where of 831 are active in 2912 developmental projects in cancer across 296 different targets. The Analytical Tool and its contents are yours to keep and data can be easily exported into Excel format for mixing with your own proprietary information.

Let our expertise work for you

While executing some of your daily tasks in our Analytical Tools you will benefit from almost two decades of our experience in perfecting features and analysis, allowing you to easily create breakdowns, tables, graphs and exports for your reports, presentations and conference attendance via our easy to use point and click interface.

Support and inspiration at your finger-tips

You also have access to a great selection of How-to Training Videos showing best practice approaches to aspects such as competitive pipeline analysis right through to many real world case examples put forward by other users of our Analytical Tools.

A tool to grow with and keep you informed

Unlike a static report which just represents a particular snapshot in time, all of BioSeeker's Analytical Tools come with one year of free online access to twice-weekly updates in both contents and features (valued at $3375), pipeline alerts and online support. You can choose to renew your access to these updates and support on a yearly basis or go completely online with our industry leading full service platform, 1stOncology.

Your key to accessing the 1stOncology Newsdesk

As a special bonus, your Analytical Tool unlocks lifetime(*) access to the 1stOncology Newdesk! This service, which is normally reserved for full 1stOncology users only, is a live stream of breaking news within the oncology industry. Updated every 5 minutes, you can tune in to specific channels such as Social Media, Clinical Trials, Intellectual Property, Financial data and Press Releases. This is a great tool to ensure your surveillance of your area of interest is complete.

Did you know?

BioSeeker's Analytical Tools are a longstanding series of products powering decision making in oncology since 1999. Transform your computer's desktop to a dedicated oncology workbench today! Request sample pages or order here to ensure you are not missing out on what you need to know.

System Requirements

  • Operating system: Windows (2000/XP/Vista/7/10) for Desktop App and Mac OSX access only via our online service.
  • Browser Application (Internet Explorer, FireFox, Chrome or Safari))
  • Internet access (to access related internet resources)

(*) In this context, lifetime access refers to the full period of time that BioSeeker Group offer a Newsdesk product or similar news based service.

Back to Top